Neurorrehabilitación farmacológica en el infarto cerebral: el potencial de la cerebrolisina.

Worldwide, cerebral vascular disease is the second cause of death and the main cause of disability. It is estimated that, from the age of 25, 1 in every 4 people in the world will suffer a cerebrovascular event in their lifetime. Cerebrolysin has neuroprotective and neurorepair properties. This paper communicates the findings of different studies of the role of cardiolysin in neuroprotection. [ABSTRACT FROM AUTHOR]